Literature DB >> 9925552

Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.

T Köhler1, M Michea-Hamzehpour, S F Epp, J C Pechere.   

Abstract

While meropenem MICs were strongly influenced by the presence or absence of the MexAB-OprM efflux pump in both OprD-proficient and -deficient strain backgrounds, MICs of imipenem and of ER-35786 remained unchanged, demonstrating that meropenem is a substrate of MexAB-OprM but not imipenem and ER-35786. In vitro, all three carbapenems selected loss of OprD as a first mechanism of resistance. However, in an OprD-deficient background, meropenem was able to select MexAB-OprM overproducers as a secondary resistance mechanism, while ER-35786 selected a mutant cross-resistant to sparfloxacin and cefpirome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925552      PMCID: PMC89097     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.

Authors:  J Trias; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  Stability of N-formimidoylthienamycin in aqueous solution.

Authors:  G B Smith; E F Schoenewaldt
Journal:  J Pharm Sci       Date:  1981-03       Impact factor: 3.534

3.  The genetic organization of arginine biosynthesis in Pseudomonas aeruginosa.

Authors:  D Haas; B W Holloway; A Schamböck; T Leisinger
Journal:  Mol Gen Genet       Date:  1977-07-07

4.  Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.

Authors:  F Yoshimura; H Nikaido
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

5.  Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.

Authors:  J C Fung-Tomc; E Gradelski; B Kolek; B Minassian; M Pucci; R E Kessler; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

6.  Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution.

Authors:  Y Takeuchi; M Sunagawa; Y Isobe; Y Hamazume; T Noguchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-04       Impact factor: 1.645

7.  Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

8.  Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant.

Authors:  B L Angus; A M Carey; D A Caron; A M Kropinski; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

9.  Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.

Authors:  N Masuda; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.

Authors:  H Y Chen; M Yuan; D M Livermore
Journal:  J Med Microbiol       Date:  1995-10       Impact factor: 2.472

View more
  75 in total

1.  Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.

Authors:  T Köhler; S F Epp; L K Curty; J C Pechère
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.

Authors:  A Lee; W Mao; M S Warren; A Mistry; K Hoshino; R Okumura; H Ishida; O Lomovskaya
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

3.  C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.

Authors:  S F Epp; T Köhler; P Plésiat; M Michéa-Hamzehpour; J Frey; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 4.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

5.  mexEF-oprN multidrug efflux operon of Pseudomonas aeruginosa: regulation by the MexT activator in response to nitrosative stress and chloramphenicol.

Authors:  Hossam Fetar; Christie Gilmour; Rachael Klinoski; Denis M Daigle; Charles R Dean; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

6.  Sensitive EDTA-based microbiological assays for detection of metallo-{beta}-lactamases in nonfermentative gram-negative bacteria.

Authors:  Patricia Marchiaro; María A Mussi; Viviana Ballerini; Fernando Pasteran; Alejandro M Viale; Alejandro J Vila; Adriana S Limansky
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

7.  AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.

Authors:  Daniel J Wolter; Nancy D Hanson; Philip D Lister
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Inactivation of efflux pumps abolishes bacterial biofilm formation.

Authors:  Malin Kvist; Viktoria Hancock; Per Klemm
Journal:  Appl Environ Microbiol       Date:  2008-10-03       Impact factor: 4.792

9.  Tn6001, a transposon-like element containing the blaVIM-3-harboring integron In450.

Authors:  Sung-Pin Tseng; Po-Ren Hsueh; Jui-Chang Tsai; Lee-Jene Teng
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

10.  Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases.

Authors:  Daniel J Wolter; Noha Khalaf; Iraida E Robledo; Guillermo J Vázquez; Maria I Santé; Edna E Aquino; Richard V Goering; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.